These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17509689)

  • 1. Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration.
    ; Apte RS; Modi M; Masonson H; Patel M; Whitfield L; Adamis AP
    Ophthalmology; 2007 Sep; 114(9):1702-12. PubMed ID: 17509689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials.
    ; D'Amico DJ; Masonson HN; Patel M; Adamis AP; Cunningham ET; Guyer DR; Katz B
    Ophthalmology; 2006 Jun; 113(6):992-1001.e6. PubMed ID: 16647134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
    ; Chakravarthy U; Adamis AP; Cunningham ET; Goldbaum M; Guyer DR; Katz B; Patel M
    Ophthalmology; 2006 Sep; 113(9):1508.e1-25. PubMed ID: 16828500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial.
    Singerman LJ; Masonson H; Patel M; Adamis AP; Buggage R; Cunningham E; Goldbaum M; Katz B; Guyer D
    Br J Ophthalmol; 2008 Dec; 92(12):1606-11. PubMed ID: 18614570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: a review.
    Kourlas H; Schiller DS
    Clin Ther; 2006 Jan; 28(1):36-44. PubMed ID: 16490578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration.
    Rosenfeld PJ; Heier JS; Hantsbarger G; Shams N
    Ophthalmology; 2006 Apr; 113(4):623.e1. PubMed ID: 16581423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegaptanib for neovascular age-related macular degeneration.
    Gragoudas ES; Adamis AP; Cunningham ET; Feinsod M; Guyer DR;
    N Engl J Med; 2004 Dec; 351(27):2805-16. PubMed ID: 15625332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.
    Rosenfeld PJ; Schwartz SD; Blumenkranz MS; Miller JW; Haller JA; Reimann JD; Greene WL; Shams N
    Ophthalmology; 2005 Jun; 112(6):1048-53. PubMed ID: 15885778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous vascular endothelial growth factor after intravitreal injection of pegaptanib or ranibizumab in patients with age-related macular degeneration.
    Sawada O; Miyake T; Kakinoki M; Sawada T; Kawamura H; Ohji M
    Retina; 2010; 30(7):1034-8. PubMed ID: 20616682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration.
    Boyer DS; Heier JS; Brown DM; Francom SF; Ianchulev T; Rubio RG
    Ophthalmology; 2009 Sep; 116(9):1731-9. PubMed ID: 19643495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study.
    Moshfeghi AA; Rosenfeld PJ; Puliafito CA; Michels S; Marcus EN; Lenchus JD; Venkatraman AS
    Ophthalmology; 2006 Nov; 113(11):2002.e1-12. PubMed ID: 17027972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of naïve lesions in neovascular age-related macular degeneration with pegaptanib.
    Quiram PA; Hassan TS; Williams GA
    Retina; 2007 Sep; 27(7):851-6. PubMed ID: 17891008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experience in the treatment of neovascular age-related macular degeneration with pegaptanib].
    Maier M; Feucht N; Huebner M; Lohmann C
    Klin Monbl Augenheilkd; 2008 Jun; 225(6):582-7. PubMed ID: 18516780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local tolerance and systemic safety of pegaptanib sodium in the dog and rabbit.
    Foy JW; Rittenhouse K; Modi M; Patel M
    J Ocul Pharmacol Ther; 2007 Oct; 23(5):452-66. PubMed ID: 17900226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term efficacy and safety profile of pegaptanib sodium for age-related macular degeneration with choroidal neovascularization--evaluation of extended phase II clinical trial].
    Pegaptanib Sodium Multi-center Study Group
    Nippon Ganka Gakkai Zasshi; 2011 Feb; 115(2):122-33. PubMed ID: 21400918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegaptanib sodium for the treatment of age-related macular degeneration.
    Apte RS
    Expert Opin Pharmacother; 2008 Feb; 9(3):499-508. PubMed ID: 18220500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.
    Joeres S; Kaplowitz K; Brubaker JW; Updike PG; Collins AT; Walsh AC; Romano PW; Sadda SR
    Ophthalmology; 2008 Feb; 115(2):347-354.e2. PubMed ID: 17628685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography findings during pegaptanib therapy for neovascular age-related macular degeneration.
    Emerson GG; Flaxel CJ; Lauer AK; Stout JT; Emerson MV; Nolte S; Wilson DJ; Klein ML
    Retina; 2007; 27(6):724-9. PubMed ID: 17621181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal pegaptanib sodium for choroidal neovascularisation secondary to age-related macular degeneration: Pan-European experience.
    Sivaprasad S; Hykin P; Saeed A; Beatty S; Grisanti S; Staurenghi G; Olea JL; Campos A; Barbosa A; Rito L; Silva R; Faria R; Eldem B; Kadayifçilar S; Kolar P; Feucht N; Maestroni L
    Eye (Lond); 2010 May; 24(5):793-8. PubMed ID: 19786957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pegaptanib sodium one-year treatment study for neovascular age-related macular degeneration].
    Tano Y;
    Nippon Ganka Gakkai Zasshi; 2008 Jul; 112(7):590-600. PubMed ID: 18702350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.